Request Deal Involvement

Warburg Pincus led a $171m Series B round in HaiHe Biopharma.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

CEC Capital

financial advisors

CEC Capital

or

Principals

CHAOS INVESTMENT

bidder

CHAOS INVESTMENT

CSPC PHARMACEUTICALS

bidder

CSPC PHARMACEUTICALS

YINGKE PRIVATE EQUITY

bidder

YINGKE PRIVATE EQUITY

HAIHE BIOPHARMA

target

HAIHE BIOPHARMA

WARBURG PINCUS LLC

bidder

WARBURG PINCUS LLC

CMB INTERNATIONAL CAPITAL

bidder

CMB INTERNATIONAL CAPITAL

LEGEND CAPITAL

bidder

LEGEND CAPITAL

CHINA INTERNATIONAL CAPITAL CORPORATION (CICC)

bidder

CHINA INTERNATIONAL CAPITAL CORPORATION (CICC)

BEIJING LANGZI ASIANA ASSET MANAGEMENT

bidder

BEIJING LANGZI ASIANA ASSET MANAGEMENT

WINFAST HOLDING

bidder

WINFAST HOLDING

SSIC CAPITAL

bidder

SSIC CAPITAL

BIOTRACK CAPITAL

bidder

BIOTRACK CAPITAL

ATLAS VENTURE LP

bidder

ATLAS VENTURE LP

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite